Industry Focus Transcripts

Analyst Joey Solitro shares his bull case on three lesser-known tech stocks that are already changing the world.

The company has been growing, albeit slowly.

The two rivals control about 70% of the market.

The company owns a variety of travel booking brands.

Fracking changed the game in global oil, but that doesn’t necessarily make it a good investment.

These two med-tech stocks raised guidance after posting blowout quarterly results.

These two former Wall Street darlings have taken a beating after posting disappointing results for the second time in a row. Are these stocks bad-news buys, or could there be more trouble ahead?

ShockWave and Guardant reported fantastic things, while Abiomed and Inogen dropped precipitously on some scary updates.

Which of the two travel gurus is the better buy? More importantly, how can they climb out of the rut they’re in?

The company owns Priceline and a number of other travel websites.

Here's what the "Industry Focus: Financials" team is keeping an eye on.

Mastercard is hiring for its new cryptocurrency division. Here's what we know so far.

A well-known whistleblower just called GE a fraud. Is he right?

Here’s what investors should know about GE’s latest drama and Fed Chair Powell’s anticipated commentary.

WeWork insists it’s worth tech company hype and valuation but doesn’t back it up.

And it's barely scratched the surface of its true potential.

The CPAP pioneer has a phenomenal track record of success, but should investors jump on board today?

The innovative oxygen therapy company has grown like gangbusters in recent years and is staring down a massive opportunity.

Historian and author Dan Albert explains the surprising and fascinating history of America’s relationship with the automobile.

It could save parents money and it may be the basis for other offers.